1.

Varicella paediatric hospitalisations in Belgium: a 1-year national survey.

2.

Varicella paediatric hospitalisations in Belgium: a 1-year national survey.

3.

Varicella paediatric hospitalisations in Belgium: a 1-year national survey.

4.

Varicella paediatric hospitalisations in Belgium: a 1-year national survey.

5.

Varicella paediatric hospitalisations in Belgium: a 1-year national survey.

6.

Varicella paediatric hospitalisations in Belgium: a 1-year national survey.

7.

Varicella paediatric hospitalisations in Belgium: a 1-year national survey.

8.

Varicella paediatric hospitalisations in Belgium: a 1-year national survey.

9.

Varicella paediatric hospitalisations in Belgium: a 1-year national survey.

1.

Twenty Years of Collaboration Between Belgium and Benin in Training Anesthesiologists for Africa.

2.

Twenty Years of Collaboration Between Belgium and Benin in Training Anesthesiologists for Africa.

3.

Twenty Years of Collaboration Between Belgium and Benin in Training Anesthesiologists for Africa.

4.

Twenty Years of Collaboration Between Belgium and Benin in Training Anesthesiologists for Africa.

5.

Twenty Years of Collaboration Between Belgium and Benin in Training Anesthesiologists for Africa.

6.

Twenty Years of Collaboration Between Belgium and Benin in Training Anesthesiologists for Africa.

7.

Twenty Years of Collaboration Between Belgium and Benin in Training Anesthesiologists for Africa.

8.

Twenty Years of Collaboration Between Belgium and Benin in Training Anesthesiologists for Africa.

9.

Twenty Years of Collaboration Between Belgium and Benin in Training Anesthesiologists for Africa.

1.

The value of seroprevalence data as surveillance tool for Lyme borreliosis in the general population: the experience of Belgium.

2.

The value of seroprevalence data as surveillance tool for Lyme borreliosis in the general population: the experience of Belgium.

3.

The value of seroprevalence data as surveillance tool for Lyme borreliosis in the general population: the experience of Belgium.

4.

The value of seroprevalence data as surveillance tool for Lyme borreliosis in the general population: the experience of Belgium.

5.

The value of seroprevalence data as surveillance tool for Lyme borreliosis in the general population: the experience of Belgium.

6.

The value of seroprevalence data as surveillance tool for Lyme borreliosis in the general population: the experience of Belgium.

7.

The value of seroprevalence data as surveillance tool for Lyme borreliosis in the general population: the experience of Belgium.

8.

The value of seroprevalence data as surveillance tool for Lyme borreliosis in the general population: the experience of Belgium.

9.

The value of seroprevalence data as surveillance tool for Lyme borreliosis in the general population: the experience of Belgium.

1.

Organ donation in Belgium 2011: the highest donation rate ever

2.

Organ donation in Belgium 2011: the highest donation rate ever

3.

Organ donation in Belgium 2011: the highest donation rate ever

4.

Organ donation in Belgium 2011: the highest donation rate ever

5.

Organ donation in Belgium 2011: the highest donation rate ever

6.

Organ donation in Belgium 2011: the highest donation rate ever

7.

Organ donation in Belgium 2011: the highest donation rate ever

8.

Organ donation in Belgium 2011: the highest donation rate ever

9.

Organ donation in Belgium 2011: the highest donation rate ever

1.

BSGIE survey on COVID-19 and gastrointestinal endoscopy in Belgium : results and recommendations.

2.

BSGIE survey on COVID-19 and gastrointestinal endoscopy in Belgium : results and recommendations.

3.

BSGIE survey on COVID-19 and gastrointestinal endoscopy in Belgium : results and recommendations.

4.

BSGIE survey on COVID-19 and gastrointestinal endoscopy in Belgium : results and recommendations.

5.

BSGIE survey on COVID-19 and gastrointestinal endoscopy in Belgium : results and recommendations.

6.

BSGIE survey on COVID-19 and gastrointestinal endoscopy in Belgium : results and recommendations.

7.

BSGIE survey on COVID-19 and gastrointestinal endoscopy in Belgium : results and recommendations.

8.

BSGIE survey on COVID-19 and gastrointestinal endoscopy in Belgium : results and recommendations.

9.

BSGIE survey on COVID-19 and gastrointestinal endoscopy in Belgium : results and recommendations.

1.

Le role des centres de convention du diabete en Belgique. ; The role of diabetes convention centres in Belgium

2.

Le role des centres de convention du diabete en Belgique. ; The role of diabetes convention centres in Belgium

3.

Le role des centres de convention du diabete en Belgique. ; The role of diabetes convention centres in Belgium

4.

Le role des centres de convention du diabete en Belgique. ; The role of diabetes convention centres in Belgium

5.

Le role des centres de convention du diabete en Belgique. ; The role of diabetes convention centres in Belgium

6.

Le role des centres de convention du diabete en Belgique. ; The role of diabetes convention centres in Belgium

7.

Le role des centres de convention du diabete en Belgique. ; The role of diabetes convention centres in Belgium

8.

Le role des centres de convention du diabete en Belgique. ; The role of diabetes convention centres in Belgium

1.

Neonatal screening improves sickle cell disease clinical outcome in Belgium.

2.

Neonatal screening improves sickle cell disease clinical outcome in Belgium.

3.

Neonatal screening improves sickle cell disease clinical outcome in Belgium.

4.

Neonatal screening improves sickle cell disease clinical outcome in Belgium.

5.

Neonatal screening improves sickle cell disease clinical outcome in Belgium.

6.

Neonatal screening improves sickle cell disease clinical outcome in Belgium.

7.

Neonatal screening improves sickle cell disease clinical outcome in Belgium.

8.

Neonatal screening improves sickle cell disease clinical outcome in Belgium.

9.

Neonatal screening improves sickle cell disease clinical outcome in Belgium.

1.

Linking clinical and population-based data in older patients with cancer in Belgium: Feasibility and clinical outcomes.

2.

Linking clinical and population-based data in older patients with cancer in Belgium: Feasibility and clinical outcomes.

3.

Linking clinical and population-based data in older patients with cancer in Belgium: Feasibility and clinical outcomes.

4.

Linking clinical and population-based data in older patients with cancer in Belgium: Feasibility and clinical outcomes.

5.

Linking clinical and population-based data in older patients with cancer in Belgium: Feasibility and clinical outcomes.

6.

Linking clinical and population-based data in older patients with cancer in Belgium: Feasibility and clinical outcomes.

7.

Linking clinical and population-based data in older patients with cancer in Belgium: Feasibility and clinical outcomes.

8.

Linking clinical and population-based data in older patients with cancer in Belgium: Feasibility and clinical outcomes.

9.

Linking clinical and population-based data in older patients with cancer in Belgium: Feasibility and clinical outcomes.

1.

Inequality in treatment use among elderly patients with acute myocardial infarction: USA, Belgium and Quebec

2.

Inequality in treatment use among elderly patients with acute myocardial infarction: USA, Belgium and Quebec

3.

Inequality in treatment use among elderly patients with acute myocardial infarction: USA, Belgium and Quebec

4.

Inequality in treatment use among elderly patients with acute myocardial infarction: USA, Belgium and Quebec

5.

Inequality in treatment use among elderly patients with acute myocardial infarction: USA, Belgium and Quebec

6.

Inequality in treatment use among elderly patients with acute myocardial infarction: USA, Belgium and Quebec

7.

Inequality in treatment use among elderly patients with acute myocardial infarction: USA, Belgium and Quebec

8.

Inequality in treatment use among elderly patients with acute myocardial infarction: USA, Belgium and Quebec

9.

Inequality in treatment use among elderly patients with acute myocardial infarction: USA, Belgium and Quebec

1.

Zicht op medische beslissingen rond het levenseinde bij pasgeborenen in Vlaanderen ; Insight into end-of-life decisions in newborns in Flanders, Belgium

2.

Zicht op medische beslissingen rond het levenseinde bij pasgeborenen in Vlaanderen ; Insight into end-of-life decisions in newborns in Flanders, Belgium

3.

Zicht op medische beslissingen rond het levenseinde bij pasgeborenen in Vlaanderen ; Insight into end-of-life decisions in newborns in Flanders, Belgium

4.

Zicht op medische beslissingen rond het levenseinde bij pasgeborenen in Vlaanderen ; Insight into end-of-life decisions in newborns in Flanders, Belgium

5.

Zicht op medische beslissingen rond het levenseinde bij pasgeborenen in Vlaanderen ; Insight into end-of-life decisions in newborns in Flanders, Belgium

6.

Zicht op medische beslissingen rond het levenseinde bij pasgeborenen in Vlaanderen ; Insight into end-of-life decisions in newborns in Flanders, Belgium

7.

Zicht op medische beslissingen rond het levenseinde bij pasgeborenen in Vlaanderen ; Insight into end-of-life decisions in newborns in Flanders, Belgium

8.

Zicht op medische beslissingen rond het levenseinde bij pasgeborenen in Vlaanderen ; Insight into end-of-life decisions in newborns in Flanders, Belgium

9.

Zicht op medische beslissingen rond het levenseinde bij pasgeborenen in Vlaanderen ; Insight into end-of-life decisions in newborns in Flanders, Belgium